Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience
- PMID: 32439209
- PMCID: PMC7180376
- DOI: 10.1016/j.jaut.2020.102473
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience
Abstract
COVID-19 has become one of the worst infectious disease outbreaks of recent times, with over 2.1 million cases and 120,000 deaths so far. Our study investigated the demographic, clinical, laboratory and imaging features of 63 patients with COVID-19 in Beijing. Patients were classified into four groups, mild, moderate, severe and critically ill. The mean age of our patients was 47 years of age (range 3-85) and there was a slight male predominance (58.7%). Thirty percent of our patients had severe or critically ill disease, but only 20% of severe and 33% of critically ill patients had been to Wuhan. Fever was the most common presentation (84.1%), but cough was present in only slightly over half of the patients. We found that lymphocyte and eosinophils count were significantly decreased in patients with severe disease (p = 0.001 and p = 0.000, respectively). Eosinopenia was a feature of higher levels of severity. Peripheral CD4+, CD8+ T lymphocytes, and B lymphocytes were significantly decreased in severe and critically ill patients, but there was only a non-statistically significant downward trend in NK cell numbers with severity. Of note is that liver function tests including AST, ALT, GGT and LDH were elevated, and albumin was decreased. The inflammatory markers CRP, ESR and ferritin were elevated in patients with severe disease or worse. IL-6 levels were also higher, indicating that the presence of a hyperimmune inflammatory state portends higher morbidity and mortality. In a binary logistic regression model, C-reactive protein level (OR 1.073, [CI, 1.013-1.136]; p = 0.017), CD8 T lymphocyte counts (OR 0.989, [CI, 0.979-1.000]; p = 0.043), and D-dimer (OR 5.313, [CI, 0.325-86.816]; p = 0.241) were independent predictors of disease severity.
Keywords: 2019 novel coronavirus disease; COVID-19; Cytokine storm; Elevated liver enzymes; Interleukin-6; Lymphocyte subsets; Mortality; Prognosis; SARS-CoV-2.
Copyright © 2020. Published by Elsevier Ltd.
Figures
Similar articles
-
Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895. JAMA Netw Open. 2020. PMID: 32492165 Free PMC article.
-
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.J Clin Virol. 2020 Jun;127:104366. doi: 10.1016/j.jcv.2020.104366. Epub 2020 Apr 10. J Clin Virol. 2020. PMID: 32302954 Free PMC article.
-
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25. Respiration. 2020. PMID: 32841948 Free PMC article.
-
Laboratory findings of COVID-19: a systematic review and meta-analysis.Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23. Scand J Clin Lab Invest. 2020. PMID: 32449374 Free PMC article.
-
The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Life Sci. 2020 Oct 1;258:118167. doi: 10.1016/j.lfs.2020.118167. Epub 2020 Jul 29. Life Sci. 2020. PMID: 32735885 Free PMC article.
Cited by
-
Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.Cytometry A. 2020 Aug;97(8):772-776. doi: 10.1002/cyto.a.24172. Epub 2020 Jul 18. Cytometry A. 2020. PMID: 32542842 Free PMC article. Review.
-
Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option?Front Pharmacol. 2020 Jul 15;11:1085. doi: 10.3389/fphar.2020.01085. eCollection 2020. Front Pharmacol. 2020. PMID: 32765279 Free PMC article. No abstract available.
-
May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?J Virol Methods. 2021 Aug;294:114198. doi: 10.1016/j.jviromet.2021.114198. Epub 2021 May 24. J Virol Methods. 2021. PMID: 34044003 Free PMC article.
-
Diabetes and COVID-19: A pooled analysis related to disease severity and mortality.Prim Care Diabetes. 2021 Feb;15(1):24-27. doi: 10.1016/j.pcd.2020.08.015. Epub 2020 Aug 29. Prim Care Diabetes. 2021. PMID: 32891525 Free PMC article. Review.
-
Severity factors in Algerian patients hospitalized for COVID-19.Tunis Med. 2021 Juillet;99(7):734-743. Tunis Med. 2021. PMID: 35261005 Free PMC article. English.
References
-
- China, o N.H.C. seventh ed. 2020. New Coronavirus Pneumonia Prevention and Control Program.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous